to investigate the roles of angiotensin ii and sodium in essential high-renin , normal-renin and low-renin hypertension , 14 patients received the competitive antagonist of angiotensin ii , saralasin , during periods of sodium depletion and repletion .
C0003009
angiotensin ii
C0036193
saralasin